Clinical Trial
Study Details
Status
RECRUITING
Study ID #
NCT05738005
Study Start
Primary Completion
Study Completion
Enrollment
40
Study Type
Interventional
Phase
N/A
Interventions
Tracking Dietary/Supplement Intake on MyFitnessPal smartphone application (app)

Amyloidosis patients will use MyFitnessPal application to track dietary intake and use of herbal/alternative supplements in from week 2-9. Patient's usage of the application and questionnaires completed by the patient at the start, Week 2 and Week 10 will determine feasibility.

Primary Outcomes
Measure
Adherence Rate
Description

The adherence is defined by the status (yes vs. no) of data recording per day; The adherence rate will be calculated by the ratio of the number of days of adherence to the total number of days of trial (i.e., 56 days); The status of data recording per day will be considered 'yes' if the participant completes a daily survey.

Timeframe
56 days
Secondary Outcomes
Measure
Subsequent adherence rate
Description

The subsequent adherence is the status of data recording per day during the third phase (Week 10) of trial participation (i.e., 7 days); The subsequent adherence rate will be calculated by the ratio of the number of days of adherence during the third phase (Week 10) of trial participation (i.e., 7 days); The status of data recording per day will be considered 'yes' if the participant completes a daily survey.

Timeframe
63 days (= 56 days + Week 10)
Summary

The goal of this clinical trial is to learn about malnutrition and weight loss in patients with Amyloidosis.

The main question it aims to answer is:

Is it feasible to use a low-cost nutrition-based application (apps) for use on a smartphone to obtain detailed information on caloric intake in Amyloidosis patients

Participants will be asked to:

* Download the MyFitnessPal application on their smartphone and view an online tutorial
* After a week of practice, from weeks 2-9, participants will enter daily dietary intake as well as daily herbal/alternative supplement intake into the MyFitnessPal application on their smartphone.
* complete a questionnaire prior to starting the application, after week 2 and at week 10 after starting the application

Conditions
Amyloidosis
Study Contact
Name
Jeffrey Zonder, MD
Role
Contact
Phone
313-576-8732
Email
zonderj@karmanos.org
Locations
Facility

Karmanos Cancer Institute
Detroit, MI 48201
United States

Contacts
Study Contact
Name
Abdul Khan, M.D.
Role
Sub-Investigator
Eligibility Criteria

Inclusion Criteria:

* 18 years of age or older
* Diagnosed with any type of amyloidosis
* Speak, read and write in English
* Willing to use the MyFitnessPal app on their own smartphone

Exclusion Criteria:

* a planned autologous stem cell transplant or a solid organ transplant in the 12 weeks after enrollment
* cognitive or perceptual disturbances

Eligibility Minimum Age
18 Years
Sexes Eligible for Study
ALL
Eligibility Std Ages
Adult
Older Adult